Page D L, Simpson J F
Division of Anatomic Pathology, Vanderbilt University Medical Center, Medical Center North, Nashville, TN 37232, USA.
Curr Opin Oncol. 1998 Nov;10(6):498-503. doi: 10.1097/00001622-199811000-00004.
Our review of recent developments in breast cancer involving the evaluation of patients' tissues is aimed at indicators of increased cancer risk (i.e., the atypical hyperplasias) and lesions without metastatic capacity at time of detection, but those lesions with sufficient risk of attaining metastasis that treatment is mandated (i.e., the ductal carcinomas in situ). We also include invasive lesions with little capacity for metastatic behavior, and highlight the histologic criteria for their recognition, as well as their biologic and clinical characterization. Also discussed are advances in the understanding of diagnostic techniques, particularly core needle biopsy.
我们对乳腺癌近期进展的综述涉及对患者组织的评估,目标是确定癌症风险增加的指标(即非典型增生)以及在检测时无转移能力的病变,但这些病变具有足够的转移风险,因此必须进行治疗(即导管原位癌)。我们还纳入了转移行为能力较弱的浸润性病变,并强调了识别它们的组织学标准以及它们的生物学和临床特征。此外,还讨论了在诊断技术理解方面的进展,特别是粗针活检。